C3i names Song business development executive in Asia

Monday, July 16, 2012 10:57 AM

C3i, which provides service desk support and business process outsourcing (BPO) services for the life sciences industry, has appointed Jonathan Song business development executive in Asia.

C3i recently opened an operations center in Dalian, China to address the IT support needs of pharmaceutical companies doing business in the main Asian markets. Song will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organizations in Asia.

Song has 20 years of pharmaceutical and healthcare experience in China and the U.S., both in industry and agency, including positions at Merck and Sinopharm.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs